Heat shock proteins Hsp90 and Hsp70 facilitate protein folding but can also direct proteins for ubiquitin-mediated degradation. The mechanisms regulating these opposite activities involve Hsp binding to co-chaperones including CHIP and HOP at their C-termini. We demonstrated that the extreme C-termini of Hsp70 and Hsp90 contain phosphorylation sites targeted by kinases including CK1, CK2 and GSK3-β in vitro. The phosphorylation of Hsp90 and Hsp70 prevents binding to CHIP and thus enhances binding to HOP. Highly proliferative cells contain phosphorylated chaperones in complex with HOP and phospho-mimetic and non-phosphorylable Hsp mutant proteins show that phosphorylation is directly associated with increased proliferation rate. We also demonstrate that primary human cancers contain high levels of phosphorylated chaperones and show increased levels of HOP protein and mRNA. These data identify C-terminal phosphorylation of Hsp70 and Hsp90 as a switch for regulating co-chaperone binding and indicate that cancer cells possess an elevated protein folding environment by the concerted action of co-chaperone expression and chaperone modifications. In addition to identifying the pathway responsible for regulating chaperone-mediated protein folding/degradation balances in normal cells, the data provide novel mechanisms to account for the aberrant chaperone activities observed in human cancer cells and have implications for the application of anti-chaperone therapies in cancer treatment.

Centre for Oncology and Molecular Medicine University of Dundee Nethergate Dundee Scotland UK

Institute of Microbiology Academy of Sciences of the Czech Republic Prague Czech Republic

Masaryk Memorial Cancer Institute Brno Czech Republic

p53 Laboratory Singapore

000      

00000naa a2200000 a 4500

001      

bmc13031898

003      

CZ-PrNML

005      

20191021104509.0

007      

ta

008      

131002s2013 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1038/onc.2012.314 $2 doi

035    __

$a (PubMed)22824801

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Müller, Petr $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0036920

245    10

$a C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances / $c P. Muller, E. Ruckova, P. Halada, PJ. Coates, R. Hrstka, DP. Lane, B. Vojtesek

520    9_

$a Heat shock proteins Hsp90 and Hsp70 facilitate protein folding but can also direct proteins for ubiquitin-mediated degradation. The mechanisms regulating these opposite activities involve Hsp binding to co-chaperones including CHIP and HOP at their C-termini. We demonstrated that the extreme C-termini of Hsp70 and Hsp90 contain phosphorylation sites targeted by kinases including CK1, CK2 and GSK3-β in vitro. The phosphorylation of Hsp90 and Hsp70 prevents binding to CHIP and thus enhances binding to HOP. Highly proliferative cells contain phosphorylated chaperones in complex with HOP and phospho-mimetic and non-phosphorylable Hsp mutant proteins show that phosphorylation is directly associated with increased proliferation rate. We also demonstrate that primary human cancers contain high levels of phosphorylated chaperones and show increased levels of HOP protein and mRNA. These data identify C-terminal phosphorylation of Hsp70 and Hsp90 as a switch for regulating co-chaperone binding and indicate that cancer cells possess an elevated protein folding environment by the concerted action of co-chaperone expression and chaperone modifications. In addition to identifying the pathway responsible for regulating chaperone-mediated protein folding/degradation balances in normal cells, the data provide novel mechanisms to account for the aberrant chaperone activities observed in human cancer cells and have implications for the application of anti-chaperone therapies in cancer treatment.

650    _2

$a nádory prsu $x metabolismus $7 D001943

650    _2

$a nádorové buněčné linie $7 D045744

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a kinasa 3 glykogensynthasy $x metabolismus $7 D038362

650    _2

$a HEK293 buňky $7 D057809

650    _2

$a proteiny tepelného šoku HSP70 $x metabolismus $7 D018840

650    _2

$a proteiny tepelného šoku HSP90 $x metabolismus $7 D018841

650    _2

$a proteiny tepelného šoku $x genetika $x metabolismus $7 D006360

650    _2

$a lidé $7 D006801

650    _2

$a fosforylace $7 D010766

650    _2

$a vazba proteinů $7 D011485

650    _2

$a sbalování proteinů $7 D017510

650    _2

$a messenger RNA $x biosyntéza $7 D012333

650    _2

$a ubikvitinligasy $x metabolismus $7 D044767

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Ruckova, Eva $u Masaryk Memorial Cancer Institute, Brno, Czech Republic

700    1_

$a Halada, Petr, $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic $d 1972- $7 xx0063115

700    1_

$a Coates, Philip J. $u Centre for Oncology and Molecular Medicine, University of Dundee, Nethergate, Dundee, Scotland, UK

700    1_

$a Hrstka, Roman $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0077297

700    1_

$a Lane, David P. $u p53 Laboratory (A*STAR), Singapore

700    1_

$a Vojtěšek, Bořivoj, $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $d 1960- $7 xx0001694

773    0_

$w MED00003600 $t Oncogene $x 1476-5594 $g Roč. 32, č. 25 (2013), s. 3101-3110

856    41

$u https://pubmed.ncbi.nlm.nih.gov/22824801 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20131002 $b ABA008

991    __

$a 20191021104942 $b ABA008

999    __

$a ok $b bmc $g 995985 $s 830343

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2013 $b 32 $c 25 $d 3101-3110 $i 1476-5594 $m Oncogene $n Oncogene $x MED00003600

GRA    __

$a NS9812 $p MZ0

GRA    __

$a NT13794 $p MZ0

LZP    __

$a Pubmed-20131002